Crohn’s Disease Associated Pyoderma Gangrenosum Treated with Adalimumab
Pyoderma gangrenosum is a known, though infrequent, ulcerative skin lesion that is often associated with systemic inflammatory and immunologic diseases. Objective: To present the efficacy of Adalimumab, a fully human Tumour Necrosis Factor-α antagonist, in the treatment of pyoderma gangrenosum assoc...
Main Authors: | Despoina Kakagia, Eleni Efremidou, Nikolaos Lyratzopoulos, Alexandros Mitrakas, Michael Pitiakoudis, George Kouklakis |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2012-03-01
|
Series: | Balkan Medical Journal |
Subjects: | |
Online Access: | http://www.tutfd.org/text.php3?id=838 |
Similar Items
-
Pyoderma Gangrenosum in Crohn’s Disease: Unusual Presentation and Management
by: Jeyaraj Nallathambi, et al.
Published: (2009-11-01) -
Pyoderma gangrenosum in a patient with Crohn’s disease: Case report and a review of the literature
by: Servet Güreşci, et al.
Published: (2010-12-01) -
Pyoderma gangrenosum and chronic granulomatous disease treated with adalimumab: Case-based review
by: Samar Tharwat, et al.
Published: (2021-04-01) -
Progression of pyoderma gangrenosum with angioinvasive fungus
by: Delice Kayishunge, BS, et al.
Published: (2021-05-01) -
Broadening the differential: A case of penile pyoderma gangrenosum
by: Patrick O. Curtin, et al.
Published: (2020-11-01)